This meeting will consist of: Review and approve drug use criteria and standards for both prospective and retrospective drug use reviews, apply these criteria and standards in the application of the DUR activities, review and report the results of drug use reviews, and recommend and evaluate educational intervention programs. The invited speaker for this meeting is: Almut Winterstein, PhD, Associate Professor, Director of FDA & UF Graduate Program in POP Research, Dept. of Pharmaceutical Outcomes & Policy (POP), College of Pharmacy, University of Florida. Dr. Winterstein will address optimal use of RSV prophylaxis in Florida Medicaid beneficiaries.